Research progress on risk factors of radiation pneumonitis caused by stereotactic body radiotherapy for non-small-cell lung cancer
10.3760/cma.j.cn113030-20200531-00287
- VernacularTitle:非小细胞肺癌立体定向放疗所致放射性肺炎相关因素研究进展
- Author:
Shoupeng FU
1
;
Yingjie ZHANG
;
Jianbin LI
Author Information
1. 潍坊医学院 261053
- Keywords:
Radiation pneumonitis;
Risk factor;
Carcinoma, non-small-cell lung/stereotactic body radiotherapy
- From:
Chinese Journal of Radiation Oncology
2021;30(12):1330-1334
- CountryChina
- Language:Chinese
-
Abstract:
Stereotactic body radiotherapy (SBRT/SABR) has become an important option in the treatment of early non-small-cell lung cancer (NSCLC). Radiation pneumonitis (RP) is the main side effect of early NSCLC patients after SBRT/SABR. Patient factors, tumor factors and treatment factors are all associated with the occurrence of RP in early NSCLC patients after SBRT/SABR. In recent years, relevant studies have further clarified the relationship between these factors and RP. In addition, the prediction factors related to RP occurrence are further discussed. In this paper, relevant research progresses in recent years were reviewed.